Acinetobacter Baumannii blood stream infections in patients admitted to intensive care units: Incidence, risk factors and future expectations

نویسندگان
doi
10.48309/jmpcr.2026.527917.1725
چکیده

Acinetobacter baumannii is a pathogenic Gram-negative bacterium known for causing severe infections in hospitalized patients, particularly those in intensive care units (ICUs). Its resistance to multiple antibiotics contributes to the prevalence of bloodstream infections (BSIs), increasing patient mortality and imposing a significant burden on healthcare systems. This study aims to determine the incidence of A. baumannii -associated BSIs in adult ICU patients, identify associated risk factors, evaluate antimicrobial resistance patterns, and assess patient outcomes. A retrospective observational study was conducted by reviewing the medical records of ICU patients admitted to Al-Azhar University Hospitals (Egypt), Hassan Ghazzawi Hospital – Abeer Medical Group, and King Abdulaziz Hospital and Oncology Centre – Jeddah (Saudi Arabia) between October 1, 2024, and March 31, 2025. Fifty-four adult patients with laboratory-confirmed A. baumannii BSIs were included. Statistical analysis was performed using SPSS, incorporating descriptive statistics, Chi-square tests, and t-tests to explore associations between clinical variables and outcomes. The study analyzed 54 ICU patients with A. baumannii BSIs. Females represented a slight majority (51.9%), and 96.3% of cases were healthcare-associated infections. Common comorbidities included diabetes mellitus (DM), hypertension (HTN), and cardiovascular diseases (CVD). Over half of the patients (55.6%) required mechanical ventilation. Notably, 74% of the isolates were classified as extensively drug-resistant (XDR). The findings indicate that most A. baumannii BSIs in ICU patients are healthcare-associated and predominantly caused by XDR strains. Risk factors include mechanical ventilation, underlying comorbidities, and inconsistent clinical data documentation. These results underscore the urgent need for improved infection control measures, robust antimicrobial stewardship programs, and enhanced medical record-keeping to reduce the burden of A. baumannii infections in critical care settings.